Memorial Healthcare: Reducing Infants Born with Neonatal Abstinence Syndrome
Memorial Healthcare System: Maternal Addiction Treatment - Preventing Neonatal Abstinence Syndrome
October 26, 3:00 ET
join a small group of your executive colleagues for a webinar and discussion. Zeff Ross, FACHE, Executive Vice President, Memorial Healthcare System (MHS) and CEO, Memorial Regional Hospital; Alberto Augsten, Pharm.D., BCPP, CPh, Pharmacy Clinical Coordinator; Laurie Scott, MD, Medical Director, High Risk Maternal/Fetal Services; Claudia Vicencio, LCSW, LMFT, Clinical Supervisor Outpatient Behavioral Health; and Tammy Tucker, Psy.D., Associate Administrator, Memorial Regional Hospital, Hollywood, FL will describe the evolution and impact of MHS’s initiative to reduce the number of babies born with Neonatal Abstinence Syndrome (NAS) by treating pregnant women with opioid addiction.
Speakers will explain what drove the creation of this initiative; the team members who implemented the treatment program and how this has improved access to care as well as quality outcomes for mothers and babies alike. They will provide details of the program structure and how it is a cost effective use of resources. Participants will hear the stories of how some of the youngest victims of the state’s opioid epidemic were treated in utero and the majority were born drug free.
If you have any questions, please contact Member Relations at 800-424-4301.
- Dr. Alberto Augsten, PharmD, BCPP, CPh
- Zeff Ross, FACHE
- Laurie Scott, MD
- Tammy Tucker, Psy.D.
- Claudia P. Vicencio, LCSW, LMFT